Ataxin-3 and its e3 partners: implications for machado-joseph disease.
Ataxin-3 and its e3 partners: implications for machado-joseph disease.
复制标题
DOI:
10.3389/fneur.2013.00046
复制
发表时间:
2013
影响因子:
3.4
通讯作者:
Fon EA
中科院分区:
文献类型:
--
作者:
Durcan TM;Fon EA
Machado–Joseph disease (MJD) is the most common dominant inherited ataxia worldwide, caused by an unstable CAG trinucleotide expansion mutation within the SCA3 gene resulting in an expanded polyglutamine tract within the ataxin-3 protein. Ataxin-3 functions as a deubiquitinating enzyme (DUB), within the Ub system and whilst many DUBs are known to partner with and deubiquitinate specific E3-Ub ligases, ataxin-3 had no identified E3 partner until recent studies implicated parkin and CHIP, two neuroprotective E3 ligases. MJD often presents with symptoms of Parkinson disease (PD), which led to identification of parkin as a novel E3-Ub ligase whose activity was regulated by ataxin-3-mediated deubiquitination. Findings from these studies also revealed an unexpected convergence upon the E2-Ub-conjugating enzyme in the regulation of an E3/DUBenzyme pair. Moreover, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway, raising the intriguing possibility that increased turnover of parkin may contribute to the pathogenesis of MJD and help explain some of the Parkinsonian features in MJD. In addition to parkin, the U-box E3 ligase CHIP, a neuroprotective E3 implicated in protein quality control, was identified as a second E3 partner of ataxin-3, with ataxin-3 regulating the ability of CHIP to ubiquitinate itself. Indeed, ataxin-3 not only deubiquitinated CHIP, but also trimmed Ub conjugates on CHIP substrates, thereby regulating the length of Ub chains. Interestingly, when expanded ataxin-3 was present, CHIP levels were also reduced in the brains of MJD transgenic mice, raising the possibility that loss of one or both E3 partners may be a contributing factor in the pathogenesis of SCA3. In this review we discuss the implications from these studies and describe the importance of these findings in helping us understand the molecular processes involved in SCA3 and other neurodegenerative disorders.
登录
查看更多内容
DOI:
10.1016/j.bbadis.2011.10.010
发表时间:
2012-02
影响因子:
6.2
作者:
Laco, Mario N.;Oliveira, Catarina R.;Paulson, Henry L.;Rego, A. Cristina
通讯作者:
Rego, A. Cristina
影响因子:
2.6
作者:
Bettencourt C;Santos C;Coutinho P;Rizzu P;Vasconcelos J;Kay T;Cymbron T;Raposo M;Heutink P;Lima M
通讯作者:
Lima M
影响因子:
16
作者:
Scaglione KM;Zavodszky E;Todi SV;Patury S;Xu P;Rodríguez-Lebrón E;Fischer S;Konen J;Djarmati A;Peng J;Gestwicki JE;Paulson HL
通讯作者:
Paulson HL
DOI:
10.1083/jcb.201210111
发表时间:
2013-01-21
期刊:
The Journal of cell biology
影响因子:
--
作者:
Lazarou M;Narendra DP;Jin SM;Tekle E;Banerjee S;Youle RJ
通讯作者:
Youle RJ
影响因子:
6.1
作者:
Pozzi, Chiara;Valtorta, Marco;Fusi, Paola
通讯作者:
Fusi, Paola